Pricing Log in Create free account

Milestone Pharmaceuticals Inc. (MIST) vs vTv Therapeutics Inc. (VTVT)

Milestone Pharmaceuticals Inc. and vTv Therapeutics Inc. are both Biotechnology companies. Milestone Pharmaceuticals Inc. and vTv Therapeutics Inc. are of similar size ($96.2M and $95.0M). vTv Therapeutics Inc. has the higher net margin (0.00% vs −1,586.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, vTv Therapeutics Inc. leads on 13 and Milestone Pharmaceuticals Inc. on 2.

Valuation

Metric MIST VTVT Biotechnology median
P/E n/m n/m 10.26
P/S 18.07 7.15 9.18
P/B 5.25 3.44 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.20 n/m 0.65
EV/Sales (2.96) 4.90 8.98
Earnings yield (100.00%) (3.53%) (34.89%)
Free cash flow yield (64.42%) (6.23%) (24.52%)

Profitability

Metric MIST VTVT Biotechnology median
Gross margin 13.27% 99.92% 65.16%
Operating margin (1,479.69%) 0.00% 0.00%
Net margin (1,586.01%) 0.00% 0.00%
Free cash flow margin (1,163.79%) 0.00% 0.00%
Return on equity (35,522.62%) (11.74%) (50.12%)
Return on assets (73.36%) (8.34%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MIST VTVT Biotechnology median
Revenue growth (TTM) — 654.58% 6.26%
EPS growth (last fiscal year) (11.94%) 0.00% 29.88%
Revenue growth, 5-year CAGR — (39.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MIST VTVT Biotechnology median
Debt to equity 3.25 0.00 0.00
Current ratio 8.13 12.48 4.89
Net debt to EBITDA 0.79 2.71 1.01

Dividend

Metric MIST VTVT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MIST VTVT Biotechnology median
Market cap 96.17m 95.02m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack